The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: No Antimicrobial Prophylaxis for Laparoscopic Distal Gastrectomy
Official Title: Phase II Study of the Efficacy of no Antimicrobial Prophylaxis Use for Laparoscopic Distal Gastrectomy for Gastric Carcinoma
Study ID: NCT02200315
Brief Summary: The aim of this study is to evaluate the feasibility and safety of no use of antimicrobial prophylaxis during laparoscopic distal gastrectomy for gastric carcinoma.
Detailed Description: This is a phase II clinical trial investigating the postoperative surgical site infection (SSI) rates after no antimicrobial prophylaxis use during laparoscopic distal gastrectomy. Target ranges of SSI rates after laparoscopic distal gastrectomy were determined based on the previous reports and our data. If SSI rates are within the target range, the investigators will proceed to a randomized controlled trial investigating the efficacy of no antimicrobial use for laparoscopic gastrectomy.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Chonnam National University Hwasun Hospital, Hwasun-eup, Jeollanam-do, Korea, Republic of
Dong-A University Hospital, Busan, Kyungsang-do, Korea, Republic of
Kyemyung University Dongsan Medical Center, Daegu, Kyungsang-do, Korea, Republic of
Name: Oh Jeong, MD, PhD
Affiliation: Chonnam National University Hospital
Role: STUDY_DIRECTOR
Name: Young Kyu Park, MD, PhD
Affiliation: Chonnam National University Hospital
Role: STUDY_CHAIR